JP2011504165A5 - - Google Patents

Download PDF

Info

Publication number
JP2011504165A5
JP2011504165A5 JP2010515076A JP2010515076A JP2011504165A5 JP 2011504165 A5 JP2011504165 A5 JP 2011504165A5 JP 2010515076 A JP2010515076 A JP 2010515076A JP 2010515076 A JP2010515076 A JP 2010515076A JP 2011504165 A5 JP2011504165 A5 JP 2011504165A5
Authority
JP
Japan
Prior art keywords
peptide
composition
sequence
administration
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010515076A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011504165A (ja
JP5587772B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/068181 external-priority patent/WO2009003034A1/en
Publication of JP2011504165A publication Critical patent/JP2011504165A/ja
Publication of JP2011504165A5 publication Critical patent/JP2011504165A5/ja
Application granted granted Critical
Publication of JP5587772B2 publication Critical patent/JP5587772B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010515076A 2007-06-27 2008-06-25 オリゴペプチドチロシナーゼインヒビターおよびその使用 Active JP5587772B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93739207P 2007-06-27 2007-06-27
US60/937,392 2007-06-27
PCT/US2008/068181 WO2009003034A1 (en) 2007-06-27 2008-06-25 Oligopeptide tyrosinase inhibitors and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014077171A Division JP2014159442A (ja) 2007-06-27 2014-04-03 オリゴペプチドチロシナーゼインヒビターおよびその使用

Publications (3)

Publication Number Publication Date
JP2011504165A JP2011504165A (ja) 2011-02-03
JP2011504165A5 true JP2011504165A5 (OSRAM) 2011-08-18
JP5587772B2 JP5587772B2 (ja) 2014-09-10

Family

ID=40186021

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010515076A Active JP5587772B2 (ja) 2007-06-27 2008-06-25 オリゴペプチドチロシナーゼインヒビターおよびその使用
JP2014077171A Pending JP2014159442A (ja) 2007-06-27 2014-04-03 オリゴペプチドチロシナーゼインヒビターおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014077171A Pending JP2014159442A (ja) 2007-06-27 2014-04-03 オリゴペプチドチロシナーゼインヒビターおよびその使用

Country Status (7)

Country Link
US (2) US7902329B2 (OSRAM)
EP (1) EP2173370B1 (OSRAM)
JP (2) JP5587772B2 (OSRAM)
KR (2) KR20150083931A (OSRAM)
CN (2) CN104083752B (OSRAM)
CA (2) CA2728122C (OSRAM)
WO (1) WO2009003034A1 (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641591B1 (en) 1999-08-26 2003-11-04 John H. Shadduck Instruments and techniques for controlled removal of epidermal layers
US8048089B2 (en) 2005-12-30 2011-11-01 Edge Systems Corporation Apparatus and methods for treating the skin
WO2014151104A1 (en) 2013-03-15 2014-09-25 Edge Systems Llc Devices, systems and methods for treating the skin
US10172644B2 (en) 2006-03-29 2019-01-08 Edge Systems Llc Devices, systems and methods for treating the skin
US9566088B2 (en) 2006-03-29 2017-02-14 Edge Systems Llc Devices, systems and methods for treating the skin
KR101836310B1 (ko) 2008-01-04 2018-03-08 엣지 시스템즈 엘엘씨 피부 처리 장치 및 방법
US9056193B2 (en) 2008-01-29 2015-06-16 Edge Systems Llc Apparatus and method for treating the skin
EP2451367B1 (en) 2009-07-08 2020-01-22 Edge Systems Corporation Devices for treating the skin using time-release substances
WO2011116072A1 (en) 2010-03-16 2011-09-22 Escape Therapeutics, Inc. Hybrid hydrogel scaffold compositions and methods of use
EP2382963A1 (en) 2010-04-29 2011-11-02 Cognis IP Management GmbH Cosmetic composition containing oligopeptides
CN102492018A (zh) * 2010-07-27 2012-06-13 萧乃文 酪氨酸酶多肽抑制剂
US10238812B2 (en) 2013-03-15 2019-03-26 Edge Systems Llc Skin treatment systems and methods using needles
US9567368B2 (en) * 2013-11-29 2017-02-14 Escape Therapeutics, Inc. Peptide tyrosinase activators
EP2990027A1 (en) 2014-09-01 2016-03-02 Institut Curie Skin whitening peptide agents
EP4324414A3 (en) 2014-12-23 2024-05-01 HydraFacial LLC Devices and methods for treating the skin using a rollerball or a wicking member
US10179229B2 (en) 2014-12-23 2019-01-15 Edge Systems Llc Devices and methods for treating the skin using a porous member
US11241357B2 (en) 2015-07-08 2022-02-08 Edge Systems Llc Devices, systems and methods for promoting hair growth
CN105177092A (zh) * 2015-09-23 2015-12-23 华侨大学 一种具有美白功效的活性多肽的生物发酵制备方法
US20180296456A1 (en) * 2017-03-30 2018-10-18 Escape Therapeutics, Inc. Decapeptide-12 Modulation of Sirtuin Gene Expression in Epidermal Keratinocyte Progenitors
CN107253977B (zh) * 2017-07-03 2020-04-28 大连理工大学 抑制黑色素生成抗氧化的小肽、制备方法及其应用
CN108837142A (zh) * 2018-07-20 2018-11-20 厦门艾赛生物科技有限公司 一种可修复皮肤的干细胞外泌体及其制备方法和应用
JP7241483B2 (ja) * 2018-07-23 2023-03-17 株式会社ノエビア 皮膚用組成物
CN108948151B (zh) * 2018-08-06 2019-06-21 山西锦波生物医药股份有限公司 肽及其制备方法和用途
MX2020014330A (es) * 2018-12-26 2021-03-09 Caregen Co Ltd Composicion para relajacion muscular.
JP7689073B2 (ja) * 2019-01-19 2025-06-05 エスケープ・セラピューティクス・インコーポレイテッド ヒト新生児ケラチノサイト前駆細胞において免疫抑制活性を有するチロシン阻害剤
CA3131382A1 (en) * 2019-02-25 2020-09-03 Topix Pharmaceuticals, Inc. Methods, compositions, sheets for therapeutic skin treatments
US11291474B2 (en) 2020-01-06 2022-04-05 Ed F. Nicolas Skin treatment tool applicator tip
US20230391825A1 (en) * 2020-10-20 2023-12-07 Escape Therapeutics, Inc. Enhanced skin permeation of a novel peptide via structural modification, chemical enhancement, and microneedles
KR102506020B1 (ko) * 2020-11-27 2023-03-06 웰펩 주식회사 항산화 활성 및 티로시나제 저해활성을 갖는 펩타이드 및 이를 포함하는 조성물
USD1065551S1 (en) 2021-09-10 2025-03-04 Hydrafacial Llc Skin treatment device
USD1016615S1 (en) 2021-09-10 2024-03-05 Hydrafacial Llc Container for a skin treatment device
USD1042807S1 (en) 2021-10-11 2024-09-17 Hydrafacial Llc Skin treatment tip
USD1084369S1 (en) 2023-02-10 2025-07-15 Hydrafacial Llc Skin treatment tip

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3978427A (en) 1973-06-15 1976-08-31 American Optical Corporation Erbium laser device having non-masking laser rod holders
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
IT1164225B (it) 1983-05-13 1987-04-08 Anic Spa Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione
EP0389950A1 (en) 1989-03-23 1990-10-03 Lion Corporation Melanocyte-stimulating hormone inhibitor and external preparation containing the same
US5773291A (en) 1989-04-26 1998-06-30 Sloan-Kettering Institute For Cancer Research Non-melanotytic mammalian cell constitutively expressing biologically active human tyrosinase and use thereof
JPH06505701A (ja) * 1990-09-10 1994-06-30 スクール・オブ・フアーマシー・ユニバーシテイ・オブ・ロンドン リポソーム
US5543389A (en) 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization Covalent polar lipid-peptide conjugates for use in salves
AU1194092A (en) 1991-02-06 1992-09-07 Georgetown University Receptor blocking peptides of fibroblast growth factor receptor
US5455228A (en) 1993-07-02 1995-10-03 The Research Foundation Of State University Of New York Peptidase resistant thrombin receptor peptide ligand
US5589460A (en) 1994-05-04 1996-12-31 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US6602856B1 (en) 1995-01-17 2003-08-05 J. Mark Quillan Antagonists of alpha-melanocyte stimulating hormone and methods based thereon
ES2175083T3 (es) 1995-03-14 2002-11-16 Praecis Pharm Inc Moduladores de la agregacion de amiloides.
DE69738930D1 (de) 1996-03-28 2008-10-02 Univ Boston Methoden zur modulation der melaninsynthese
US6143723A (en) * 1996-05-20 2000-11-07 Ramaiah; Abburi Pigmentory agent
US6165982A (en) 1996-11-08 2000-12-26 Seiren Co., Ltd. Use of sericin as antioxidants and tyrosinase inhibitors
US6982249B1 (en) 1997-04-23 2006-01-03 The Regents Of The University Of Michigan Bradykinin analogs as selective inhibitors of cell activation
US6368877B1 (en) 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions
US6287590B1 (en) 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
US6323219B1 (en) 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
US6663659B2 (en) * 2000-01-13 2003-12-16 Mcdaniel David H. Method and apparatus for the photomodulation of living cells
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US20020034772A1 (en) 1999-06-29 2002-03-21 Orlow Seth J. Methods and compositions that affect melanogenesis
US7083781B2 (en) 1999-08-19 2006-08-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
US6283978B1 (en) * 2000-06-09 2001-09-04 Peter J. Cheski Method and apparatus for microdermabrasion
CA2412011A1 (en) 2000-06-16 2001-12-27 Hercules Incorporated Chemically-modified antimicrobial peptides, compositions and methods of production and use
US20020182237A1 (en) 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
JP2004535792A (ja) 2001-04-27 2004-12-02 ザ ジェネラル ホスピタル コーポレーション チロシナーゼアッセイ法
US7658742B2 (en) * 2001-11-21 2010-02-09 Envy Medical, Inc. Skin treatment system and method of use
US6695853B2 (en) 2001-11-21 2004-02-24 Emed, Inc. Microdermabrasion system and method of use
US6649150B2 (en) 2002-04-11 2003-11-18 Em Industries Skin-lightening
US7025957B2 (en) 2002-09-06 2006-04-11 Desert Whale Jojoba Company Composition and method to whiten skin
US7125572B2 (en) 2004-05-14 2006-10-24 Kaoder Industry Company, Ltd. Tyrosinase inhibitor extract
WO2007001868A1 (en) 2005-06-28 2007-01-04 Genentech, Inc. Egfr and kras mutations
FR2890859B1 (fr) 2005-09-21 2012-12-21 Oreal Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase

Similar Documents

Publication Publication Date Title
JP2011504165A5 (OSRAM)
JP2010531892A5 (OSRAM)
JP2016516023A5 (OSRAM)
MX2011008616A (es) Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
WO2011047868A3 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
WO2018154145A3 (en) Retinol replacement in skin treatment
WO2010097480A3 (en) Menthyl carbamate compounds as skin and/or hair lightening actives
MX337830B (es) Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
KR20120058371A (ko) 금속단백분해효소 억제제를 포함하는 화장품 또는 약학적 조성물
KR20150090922A (ko) 피부, 모발 및／또는 점막의 치료 및／또는 관리에 유용한 화합물 및 이들의 미용적 또는 약제학적 조성물
WO2014160103A3 (en) Treatment of skin, including aging skin, to improve appearance
JP2010235608A (ja) アルファ−ｍｓｈの拮抗複合ジペプチドを含む組成物
JP2016513107A5 (OSRAM)
PH12017500136A1 (en) Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses thereof
JP2016501866A5 (OSRAM)
NZ708990A (en) Method for activating helper t cell
NZ705389A (en) Methods of treating hair related conditions
JP2015528479A5 (OSRAM)
WO2012157734A1 (ja) 胎盤由来成分を含有するシワ改善用組成物
CL2007003318A1 (es) Compuestos derivados de 4,5-difenil-pirrol-2-carboxamida; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento o la prevencion de enfermedades tales como sindrome de abstinencia a una sustancia, t
WO2009106715A3 (fr) Peptide derive d'une proteine de la famille des aquaporines
JP2009019008A (ja) 不織布含浸化粧料
WO2018106794A3 (en) Compositions and methods relating to molecular cerium-oxide nanoclusters
RS55286B1 (sr) Stabilna formulacija peksiganana
WO2024260465A1 (en) New multi-functional oligopeptides